학술논문

Clinical and pharmacokinetic phase I trial of oral dimethylaminoetoposide (NK611) administered for 21 days every 35 days
Document Type
Article
Source
In: Investigational New Drugs. (Investigational New Drugs, 1996, 14(4):379-386)
Subject
Language
English
ISSN
01676997